hemangiol
pierre fabre medicament - propranololhydrochlorid - hemangioma - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
propal retard 160 mg depotkapsler, hårde
sandoz a/s - propranololhydrochlorid - depotkapsler, hårde - 160 mg
propal retard 80 mg depotkapsler, hårde
sandoz a/s - propranololhydrochlorid - depotkapsler, hårde - 80 mg
propranolol "dak" 10 mg filmovertrukne tabletter
orifarm healthcare a/s - propranololhydrochlorid - filmovertrukne tabletter - 10 mg
propranolol "dak" 40 mg filmovertrukne tabletter
orifarm healthcare a/s - propranololhydrochlorid - filmovertrukne tabletter - 40 mg
propranolol retard "2care4" 160 mg depotkapsler, hårde
2care4 aps - propranololhydrochlorid - depotkapsler, hårde - 160 mg
propranolol retard "2care4" 80 mg depotkapsler, hårde
2care4 aps - propranololhydrochlorid - depotkapsler, hårde - 80 mg
propranolol retard "europharma" 160 mg depotkapsler, hårde
europharma.dk aps - propranololhydrochlorid - depotkapsler, hårde - 160 mg
propranolol retard "europharma" 80 mg depotkapsler, hårde
europharma.dk aps - propranololhydrochlorid - depotkapsler, hårde - 80 mg
propranolol retard "paranova" 80 mg depotkapsler, h?rde
paranova danmark a/s - propranololhydrochlorid - depotkapsler, hårde - 80 mg